FDA's Opioid Regret? Skipping Another Zohydro Meeting, Califf Says
This article was originally published in The Pink Sheet Daily
Agency addressed post-marketing concerns raised by advisory committee, Commissioner tells Senate, but should have returned to get panel's blessing.
Register for our free email digests: